Citations

Clear

246 citation(s) found for "Study, Alfa".

O4–04–07: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlation between rates of change on MRI and cognitive/behavioral measures
Petersen, Ronald C. , Grundman, Michael, Ward, Chadwick P., Jin, Shelia , Gamst, Anthony, Sencakova, Drahomira, Thal, Leon J., Group, The Alzheimer's Disease Cooperative Study, Jack, Clifford R. , Group, The Alzheimer's Disease Cooperative Study

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2006.05.324 Get It

IC–P–104: Imaging biomarkers to monitor treatment effects for Alzheimer's disease trials: The Alzheimer's disease imaging initiative
Weiner, Michael W. , Thal, Leon J., Petersen, Ronald C. , Jagust, William J. , Trojanowski, John Q. , Jack, Clifford R. , Beckett, Laurel

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_22 | Pages: No page available

10.1016/j.jalz.2006.05.2310 Get It

IC–P–096: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status
Thal, Leon J., Grundman, Michael, Ward, Chadwick P., Sencakova, Drahomira, Jin, Shelia , Gamst, Anthony, Petersen, Ronald C. , Group, The Alzheimer's Disease Cooperative Study, Jack, Clifford R. , Group, The Alzheimer's Disease Cooperative Study

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_22 | Pages: No page available

10.1016/j.jalz.2006.05.2300 Get It

IC–P–094: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlation between rates of change on MRI and cognitive/behavioral measures
Petersen, Ronald C. , Grundman, Michael, Ward, Chadwick P., Jin, Sheila, Gamst, Anthony, Sencakova, Drahomira, Thal, Leon J., Group, The Alzheimer's Disease Cooperative Study, Jack, Clifford R. , Group, The Alzheimer's Disease Cooperative Study

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_22 | Pages: No page available

10.1016/j.jalz.2006.05.2298 Get It

P3–120: Predictors of dropout in clinical trials of subjects with mild cognitive impairment (MCI)
Jin, Sheila, Bochenek, Jackie, Thal, Leon J., Petersen, Ronald C. , Sano, Mary , Edland, Steven D. , Emond, Jennifer A.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_13 | Pages: No page available

10.1016/j.jalz.2006.05.1388 Get It

P2–254: Imaging biomarkers to monitor treatment effects for Alzheimer's disease trials: The Alzheimer's disease imaging initiative
Weiner, Michael W. , Thal, Leon J., Petersen, Ronald C. , Jagust, William J. , Trojanowski, John Q. , Jack, Clifford R. , Beckett, Laurel

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1093 Get It

P2–186: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status
Thal, Leon J., Grundman, Michael, Ward, Chadwick P., Sencakova, Drahomira, Jin, Shelia , Gamst, Anthony, Petersen, Ronald C. , Group, The Alzheimer's Disease Cooperative Study, Jack, Clifford R. , Group, The Alzheimer's Disease Cooperative Study

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1024 Get It

P2–171: Clinical predictors of progression to Alzheimer's disease in amnestic mild cognitive impairment
Fleisher, Adam , Sowell, B. Brooke, Taylor, Curtis, Gamst, Anthony, Petersen, Ronald C. , Thal, Leon J.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1009 Get It

Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?
Grundman, Michael, Petersen, Ronald C. , Bennett, David A. , Feldman, Howard , Salloway, Stephen , Thal, Leon J., Schenk, Dale, Khachaturian, Zaven S., Thies, William, Visser, Pieter Jelle , Bennett, David A. , Feldman, Howard H

Mayo Clinic

Alzheimer's & Dementia | June 14, 2006 | Volume: 2 | Issue: 3 | Pages: 220-233

10.1016/j.jalz.2006.04.010 | PMID 19595891 Get It

The biological changes that occur in the brains of Alzheimer's disease (AD) patients are thought to begin long before the onset of clinical symptoms. Although current therapeutic agents have been approved only for patients with mild to moderate AD, Alzheimer‐type pathology in patients with mild to moderate AD is already quite advanced. One impetus for the development of the concept of mild cognitive impairment (MCI) was the attempt to recognize AD early in its clinical expression and to determine whether it is possible through therapeutic interventions to improve the memory impairment at this stage or delay further progression to dementia. To this end, several clinical trials have been conducted in patients with MCI. On September 8 and 9, 2004 a meeting of the Alzheimer's Association Research Roundtable was held at which experts in the field of MCI convened to review the collective experience from these trials and to consider potential approaches that might improve MCI clinical trials in the future. This article summarizes the presentations and discussions of that meeting.